Precision Biosciences (DTIL) Short term Debt (2021 - 2024)
Precision Biosciences (DTIL) posted quarterly Short term Debt of $22.5 million for Q2 2024, up 0.79% year-over-year from $22.3 million in Q3 2023, and little changed quarter-over-quarter from $22.5 million in Q1 2024.
Precision Biosciences (DTIL) Short term Debt (2021 - 2024) Analysis & Trends
Precision Biosciences (DTIL) has reported Short term Debt for 3 consecutive years, with $22.5 million the latest figure, recorded in Q2 2024.
- In Q2 2024, Short term Debt rose 0.79% year-over-year to $22.5 million; the TTM figure through Jun 2024 stood at $22.5 million (up 0.79% YoY), while the FY2023 annual figure was $22.4 million, changed N/A from the prior year.
- Short term Debt steadied at $22.5 million in Q2 2024 per DTIL's latest filing, from $22.5 million in the prior quarter.
- Across five years, Short term Debt topped out at $22.5 million in Q2 2024 and bottomed at $2.4 million in Q2 2021.
- Historically, Short term Debt has averaged $16.7 million across 3 years, with a median of $22.4 million in 2023.
- On a YoY basis, Short term Debt climbed as much as 0.79% in 2024 and fell as far as 0.79% in 2024.
- Precision Biosciences' Short term Debt stood at $2.5 million in 2021, then surged by 813.28% to $22.4 million in 2023, then advanced by 0.37% to $22.5 million in 2024.
- Business Quant data shows DTIL's Short term Debt at $22.5 million in Q2 2024, $22.5 million in Q1 2024, and $22.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Precision Biosciences | 228.31 Mn | 140.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 22.49 Mn |
| Mar 31, 2024 | 22.46 Mn |
| Dec 31, 2023 | 22.41 Mn |
| Sep 30, 2023 | 22.37 Mn |
| Jun 30, 2023 | 22.32 Mn |
| Sep 30, 2021 | 2.45 Mn |
| Jun 30, 2021 | 2.43 Mn |